TELEMAN DAN BENJAMIN (Chief Executive Officer) purchased 4.2% of their position (6.55K shares) of NASUS PHARMA LTD on the open market
Open‑market purchase worth $20.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/22/2026ACC: 0001493152-26-029484
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+6.55K
Net shares
Net buyer
$20.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.55K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+6.55K
Price / share
$3.10
Trade value
$20.30K
% of position
4.2%
6/17/2026
156.99K→163.54K
Total
Net shares
+6.55K
Net value
$20.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/17/2026 | P · Purchase | +6.55K | $3.10 | $20.30K | 4.2% | 156.99K | 163.54K |
| Total | +6.55K | $20.30K | ||||||
Derivative Transactions0
No derivative transactions reported